Bookmark Website  | Free Registration  | The Team
The Lounge  | Champions  | The Wire |  Schedule |  Audio  |  Arcade  |  The Top Ten  |  Historical  |  Email  |  Video

Congestive Heart Failure And CoQ10


Since the 1960â??s there have been numerous controlled clinical trials concerning the relationship between congestive heart failure and Coenzyme Q10 (CoQ10). As its name implies CoQ10 is a coenzyme that is necessary for the proper functioning of other substances, one of the most important of which is ATP (adenosine triphosphate). ATP is necessary for the production of cellular energy. By proxy CoQ10 is likewise essential for this process.

Clinical trials have attempted to study the relationship between CoQ10 and many chronic diseases including, but not limited to, heart disease, cancer and AIDS. But heart disease has gained the most attention; congestive heart failure being one of the primary subjects. Because heart muscle cells require so much energy to function and CoQ10 is at the core of the cellular energy process it makes sense to suspect that congestive heart failure might be linked to CoQ10 deficiency. With that theory in mind many studies like the ones that follow have been conducted. These trials have been presented in this essay in thumbnail format.

One early Japanese trial (1972) involved 197 patients with varying levels of severity of cardiac failure. The study reported significant improvement of cardiac function supplementing with 30 mg per day of CoQ10. Another Japanese study demonstrated similar results with 38 patients also supplementing with 30 mg. In 1985 a U.S. clinical study prescribed daily supplementation with 100 mg of the coenzyme for treatment periods of three months for patients with low ejection fraction measurements. The ejection fraction is the measure of the heartâ??s ability to pump blood. A low ejection fraction is a classic symptom of congestive heart failure. Again, significant improvements in heart function were reported. Other clinical trials followed prescribing the same level of supplementation with similar results.

Studies in the early 1990s showed improvement for patients suffering from ischemic cardiomyopathy (a low oxygen state usually due to obstruction) with supplemental levels of 200 mg per day. Supplementing with 100 mg per day demonstrated improvement for patients suffering from idiopathic dilated cardiomyopathy, an enlarged heart syndrome of unknown cause.

One of the largest trials of the 1990s involves 641 patients randomly divided into two groups. The first group received a placebo. The other group received CoQ10 supplements. During the one-year follow-up period 118 patients in the placebo group were hospitalized for heart failure compared to 73 in the group that received the supplements.

All of the preceding trials were relatively short-term studies. The level of improvement among patients varied depending on how long they had been suffering from some aspect of congestive heart failure. Through the years it has become increasing clear that the greatest improvements were shown in patients that had suffered from their condition the least amount of time.

In other words, the longer a person had been suffering from the disease before he or she received CoQ10 treatments the less improvement was demonstrated. People who had received treatments early in the development of the disease showed the most dramatic improvement often returning to normal heart function. Long-term sufferers received less relief and were less likely to return to full heart function. Whatever the reasons for this disparity in health improvement, it demonstrates the importance of receiving treatment as early as possible.

But what about long-term studies? Do they show the same marked improvement with similar treatment? In the short-term trials it was apparent that even high level supplementing with CoQ10 seemed to produce no ill effects. In order to determine if this is only true for short durations a number of long-term studies were conducted.

In 1990 observations were published concerning 126 patients with dilated cardiomyopathy. Unlike previously noted studies this one followed the patientsâ?? progress for six years. Long-term benefits from CoQ10 supplementing were noticed with no harmful side effects. Similar observations were made in a trial involving 2,664 patients treated with CoQ10 at levels up to 150 mg per day.

A 1994 study involving 424 patients with a variety of myocardial (refers to the heart's muscle mass) diseases. Among these conditions were the following: Valvular heart disease (pertaining to dysfunction of heart valves), hypertension, diastolic dysfunction (failure of the heart to properly refill itself with blood), dilated cardiomyopathy (group of disorders where the heart muscle is weakened and enlarged and cannot pump effectively) and ischemic cardiomyopathy (low oxygen state usually due to obstruction of the arterial blood supply).

Patients were treated with an average of 240 mg of CoQ10 daily during their treatment period. They were then followed-up for up to eight years with an average follow-up period of 18 months. Overall results demonstrated measurable cardiac improvements in one month with maximum improvements at about six months. With continued CoQ10 treatment the improvement in most patients was sustained. However, discontinuing the treatment usually resulted in a decline of cardiac function with eventual return to pre-treatment conditions.

As always in the medical community many more studies will need to be conducted to determine the future of CoQ10 treatment. However, the research to date seems to support CoQ10 as a viable treatment for many diseases that are caused or exacerbated by inadequate production of cellular energy.

Greg holds degrees in science, divinity and philosophy and is currently an I.T. developer.

http://www.optimal-heart-health.com/coq10.html


MORE RESOURCES:

Male eating disorder? New report on workout supplements
Military Times
Theodore recently co-wrote a paper with psychologist Richard Achiro to study whether the use of dietary supplements such as protein powders, creatine and other performance- and muscle-enhancing boosters contribute to unhealthy eating habits — and ...



Care2.com

Well | Supplements Don't Fight Cognitive Decline, NIH Study Says
New York Times (blog)
The study, conducted by the National Institutes of Health, randomly assigned participants to take a lutein/zeaxanthin supplement, a supplement of omega-3 long-chain polyunsaturated fatty acids with docosahexaenoic acid (DHA) and eicosapentaenoic acid ...
Omega-3 Supplements: The $1.2 Billion Industry That Doesn't WorkCare2.com
Study finds fish oil supplements lackingThe Columbian
If Fish Is Brain Food, Can Fish Oil Pills Boost Brains, Too?NPR
Sydney Morning Herald -The California Post
all 40 news articles »


FDA cracks down on dietary supplements
The Hill (blog)
In April this year, the FDA expanded its policy of restricting the sale of adulterated dietary supplements containing untested additives. Many of the substances targeted are dangerous and worthy of restriction. The synthetic additive DMAA is one such ...



WatertownDailyTimes.com

Lowdown on taking vitamins, supplements
WatertownDailyTimes.com
“People ask me this question quite often: 'Should I be taking certain vitamins and supplements?' And the answer is, quite honestly, 'It depends,'” says Anne Harguth, registered dietitian at Mayo Clinic Health System. According to the Dietary Guidelines ...
Multivitamins and supplements: To take or not to take?Duluth News Tribune

all 2 news articles »


Novacare recalls dietary supplements
ConsumerAffairs
A Washington, D.C., reporter for more than 30 years, Jim Limbach covers the federal agencies for ConsumerAffairs. Previously, he was a reporter and news anchor for Associated Press Broadcast Services, where he covered business and consumer news as ...

and more »


Fox Topix: Dietary Supplements
9&10 News
This morning, money reporter Stacy Johnson is talking about dietary supplements such as vitamins and their cost. He says just because you pay more, you don't necessarily get more bang for your buck. Millions of people take dietary supplements to stay ...



Neighborhood website supplements over-the-fence chat
Iowa City Press Citizen
In this irony-filled world, it sometimes takes a national online social media website to connect with your neighbors just a few houses up the street. That social media site is called Nextdoor and it's making headway in our Deerfield Addition at the far ...

and more »


Quad City Times

Environmental Nutrition: Take supplements safely
Quad City Times
More than half of Americans use dietary supplements, including multivitamins and botanical supplements, in tablet, capsule, liquid and powder form, says the Centers for Disease Control and Prevention. While dietary supplements -- products intended to ...



Food Poisoning Bulletin

One Minute Miracle Recalls Dietary Supplements
Food Poisoning Bulletin
The One Minute Miracle Inc. is recalling dietary supplements Miracle Diet 30 capsules and Miracle Rock 48 for undeclared drugs. No reports of illness or adverse reactions have been received to date. Both drugs were distributed via the internet nationwide.



Newsweek

Omega 3 is still good for the brain. But 'fish oil supplements just don't cut it.'
Washington Post
Consumers may want to rethink popping fish oil pills if they're hoping those supplements full of omega-3 fatty acids will keep their brains healthy. A new study--one of the largest and longest in duration of its kind--finds that taking omega-3 ...
Omega-3 Supplements Are a Waste of MoneyNewsweek
Study questions benefits of fish oil supplementsFox News
NIH study shows no benefit of omega-3 or other nutritional supplements for ...National Institutes of Health (press release)
Chicago Tribune -Mother Nature Network (blog)
all 161 news articles »

Google News


Advertisement



Section Site Map - Submit News - Feedback - Comments - Advertise with Us

Copyright © 2006 Luminati Inc. All rights reserved.